- Home
- MARPS vs XAIR Comparison
MARPS vs XAIR Comparison
Compare MARPS & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MARPS | XAIR |
|---|---|---|
| Founded | 1956 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1M | 10.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MARPS | XAIR |
|---|---|---|
| Price | $4.22 | $0.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | 22.8K | ★ 138.8K |
| Earning Date | 02-13-2026 | 02-09-2026 |
| Dividend Yield | ★ 8.66% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.31 | N/A |
| Revenue | $965,040.00 | ★ $5,802,000.00 |
| Revenue This Year | N/A | $128.45 |
| Revenue Next Year | N/A | $153.25 |
| P/E Ratio | $13.26 | ★ N/A |
| Revenue Growth | N/A | ★ 147.74 |
| 52 Week Low | $3.34 | $0.67 |
| 52 Week High | $7.90 | $10.40 |
Technical Indicators
Market Signals| Indicator | MARPS | XAIR |
|---|---|---|
| Relative Strength Index (RSI) | 43.90 | 26.25 |
| Support Level | $4.11 | $0.67 |
| Resistance Level | $4.44 | $1.31 |
| Average True Range (ATR) | 0.28 | 0.06 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 5.18 | 16.64 |
Price Performance
Historical ComparisonAbout MARPS Marine Petroleum Trust Units of Beneficial Interest
Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.